ImmunoACT
Blood & Organ Banks · India · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Immunoact 1st floor r-977 T.t.c. Industr...Website
www.immunoact.comRevenue
<$5 MillionIndustry
About ImmunoACT
ImmunoACT specializes in CAR-T cell therapy, providing advanced treatment options for blood cancers such as lymphoma and leukemia in India. The company focuses on making innovative cancer therapies accessible and affordable, leveraging indigenous technology developed at IIT Bombay. With a commitment to high-quality manufacturing and a strong network of over 130 partner hospitals, ImmunoACT aims to redefine cancer care and improve patient outcomes. Their flagship product, NexCAR19, is India's first approved CAR-T therapy, showcasing impressive remission rates and a rapid manufacturing process.Explore more
ImmunoACT Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
ImmunoACT Tech Stack
A closer look at the technologies used by ImmunoACT
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ImmunoACT
Sign Up For FreeTo access detailed company insights
ImmunoACT specializes in CAR-T cell therapy, providing advanced treatment options for blood cancers such as lymphoma and leukemia in India. The company focuses on making innovative cancer therapies accessible and affordable, leveraging indigenous technology developed at IIT Bombay. With a commitment to high-quality manufacturing and a strong networ... Read More
